30 results on '"Ratajczak, Christine K"'
Search Results
2. Efficacy and safety of first-line veliparib and carboplatin–paclitaxel in patients with HER2− advanced germline BRCA+ breast cancer: Subgroup analysis of a randomised clinical trial
3. Progression-free survival by investigator versus blinded independent central review in newly diagnosed patients with high-grade serous ovarian cancer: Analysis of the VELIA/GOG-3005 trial
4. Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial
5. A first-in-human, phase 1, dose-escalation study of ABBV-176, an antibody-drug conjugate targeting the prolactin receptor, in patients with advanced solid tumors
6. Exposure–response analysis to inform the optimal dose of veliparib in combination with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer patients
7. A phase 1 study of PARP-inhibitor ABT-767 in advanced solid tumors with BRCA1/2 mutations and high-grade serous ovarian, fallopian tube, or primary peritoneal cancer
8. Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial
9. Exposure‐Response Model With Time‐Varying Predictors to Estimate the Effects of Veliparib in Combination With Carboplatin/Paclitaxel and as Monotherapy: Veliparib Phase 3 Study in BRCA ‐Mutated Advanced Breast Cancer (BROCADE3) Trial
10. Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer:subgroup analyses by germline BRCA1/2 mutations and hormone receptor status from the phase-3 BROCADE3 trial
11. TAK1 targeting by glucocorticoids determines JNK and IκB regulation in Toll-like receptor–stimulated macrophages
12. Relevance of Platinum-free Interval and BRCA Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for gBRCA Advanced Breast Cancer (BROCADE3 Crossover)
13. sj-docx-1-tam-10.1177_17588359211059601 ��� Supplemental material for Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: subgroup analyses by germline BRCA1/2 mutations and hormone receptor status from the phase-3 BROCADE3 trial
14. Abstract PS11-03: Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: A subgroup analysis of germline BRCA1 or BRCA2 mutations from the phase 3 BROCADE3 trial
15. Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: subgroup analyses by germline BRCA1/2 mutations and hormone receptor status from the phase-3 BROCADE3 trial
16. Hypoxia regulates the expression of fatty acid–binding proteins in primary term human trophoblasts
17. The PI3K/Akt pathway is present and functional in the preimplantation mouse embryo
18. Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: subgroup analyses by germline BRCA1 / 2 mutations and hormone receptor status from the phase-3 BROCADE3 trial.
19. Abstract PD4-01: First-line veliparib plus carboplatin/paclitaxel in patients with HER2-negative advanced/metastatic gBRCA-associated breast cancer: Planned subgroup analysis from the phase 3 BROCADE3 trial
20. Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
21. Impaired Steroidogenesis and Implantation Failure in Bmal1−/− Mice
22. Generation of myometrium-specific Bmal1 knockout mice for parturition analysis
23. Preventing preterm birth: the past limitations and new potential of animal models
24. Clock gene expression in gravid uterus and extra-embryonic tissues during late gestation in the mouse
25. Clock Gene Expression in Pregnancy-Related Tissues During Late Gestation in the Mouse.
26. Impaired Steroidogenesis and Implantation Failure in Bmal1−/− Mice
27. Insights Into Parturition Biology From Genetically Altered Mice
28. Normal Follicle Development and Oocyte Maturation in Bmal1 Null Females Indicates Other Defects Responsible for Reproductive Failure.
29. Normal Follicle Development and Oocyte Maturation in Bmal1Null Females Indicates Other Defects Responsible for Reproductive Failure.
30. Relevance of Platinum-free Interval and BRCA Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for g BRCA Advanced Breast Cancer (BROCADE3 Crossover).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.